BE Health facilitates awareness raising programmes, diagnosis and treatment of infectious diseases for its corporate sector members, their employees, families and local communities.
BE Health’s day-to-day management and project coordination is handled by BE Health Management Company S.A., a Swiss corporation, whose sole purpose is the management of BE Health in accordance with BE’s statutes.
BE Health offers businesses a ready-to-use road map to prevent the spread of infectious diseases by empowering employees and their communities with the most effective tool of all: knowledge.
Once a peer health education programme is designed, it follows a simple structure to maximise its impact:
Throughout the implementation of each programme, BE Health stands by the hosting member company and assesses any challenges that may develop in order to find long-term solutions.
BE Health Association’s activities are supervised by its Board of Directors, which is the executive body of the Association. The General Assembly has appointed Deloitte S.A. as BE’s auditor to review the books and records on a yearly basis. The Managing Director of BE is in charge of BE’s operation and administration.
Chairman of the Board
Studied economics at the University of Würzburg in Germany, and worked for Commerzbank AG in corporate banking in London and Atlanta. Markus added an MBA degree from the Ecole Hotelière de Lausanne in Switzerland to his CV and started his career in the hospitality industry in 2002 as part of Kempinski’s Development team. Markus is Kempinski’s Chairman of the Management Board & CEO.
Member of the Board
Joined Bloch & Partner in 1996 and became a partner in 2000. He received his law degrees from the Universities of Berne and Basle (Switzerland) and is a member of the Swiss Bar. While an associate in a major New York law firm, he gained valuable experience in various matters of international corporate law. Robert is a board member of several Swiss and foreign corporations and has experience as a start-up entrepreneur and executive of small and medium-sized companies.
Member of the Board
Has a DEC in Social Science from Valleyfield CEGEP, Quebec; a marketing degree from ESP – a Paris Communication and Marketing School; and a DULCO in Arabic language and civilization from Langues Orientales, Paris. Caroline has a remarkable career in advertising, PR and rebranding for major companies and has developed a unique approach to innovation in service industries. Caroline has been with WPP communications group for over 15 years, based in Europe, North America and Asia. She is currently head of global brand strategy for Peclers, a trend forecasting agency.
Member of the Board
Studied geography, economics and political science at the University of Heidelberg. She joined HELLWEG in 1996 and started her career in the development department. Since 2002 Katharina has been Managing Director of Hellweg and responsible for the real-estate, construction and insurance divisions. Katharina has a senior business experience and deep passion for employee and community wellbeing.
Gained extensive experience in applied research and project management while working as scientific collaborator at the University of Geneva in Switzerland, and by managing innovative cross-border pilot projects in the European Union with an association funded by the Swiss Confederation. From 2006 to 2014, Anne-Marie worked at Kempinski Hotels, where she was in charge of conducting various company-wide projects, including the conceptualization and roll-out of BE Health Association. Anne-Marie has a BA in Sociology and a minor in Economic History from the University of Geneva, and a Research Master’s in Sociology from the University of Geneva. She also is a qualified mediator.
Chairman of the Advisory Board and a leading expert in Tuberculosis, Dr. Raviglione is professor in Global Health at the University of Milan. He joined World Health Organisation (WHO) in 1991 to work on TB/HIV research and TB epidemiology in Europe and has been Director of the Global TB Programme at the WHO since 2003. As a leading expert in TB and amongst the top ten most cited authors in the TB field. Dr Raviglione provides BE Health with his active support and vital advice to develop resourceful strategies related to community-based TB programmes.
B.N, M.A, PhD is the President and founding member of the TB/HIV Research Foundation in Chiang Rai, Thailand. She is also a senior researcher at The Research Institute of Tuberculosis, Japan Anti-Tuberculosis Association in Tokyo, Japan.
Kitty van Weezenbeek (MD, PhD, MPH) is the Executive Director of KNCV Tuberculosis Foundation, a 115-year-old Dutch TB NGO and global player in TB control (www.kncvtbc.org).
Kitty has dedicated her entire career to tuberculosis. Prior to joining the WHO in 2004, she worked with KNCV for 23 years. During her time with WHO in Geneva and the Western Pacific Region and specialist in MDR-TB, she also was Board member of several international organizations involved in TB control such as the Stop TB Partnership Coordinating Board. In 2016 she became member of the WHO Strategic and Technical Advisory Group for Tuberculosis (STAG-TB). Over the last 30 years she has contributed to a large number of national and international (WHO) guidelines and published more than 50 scientific papers.
Dr Mukund Uplekar has recently retired as a senior medical officer in the policy, strategy and innovations unit of the Global TB Programme at the World Health Organization in Geneva. Before joining WHO, Geneva, he was a private physician practicing in Mumbai, India, while also engaged in community health research. At the WHO, Dr Uplekar was instrumental in formulating, experimenting and promoting global policies and strategies for engaging private care providers in TB response through “public-private mix (PPM)” approaches. Since its inception, he led the WHO-based Secretariat of the Stop TB Partnership’s global Working Group on PPM for TB care and prevention, while coordinating the departmental group responsible for development and drafting of WHO’s expanded DOTS strategy in 2002, the Stop TB Strategy in 2006 and the current End TB Strategy. He is currently based in Mumbai and Pune.